Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ICP-248 by InnoCare Pharma for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
ICP-248 is under clinical development by InnoCare Pharma and currently in Phase I for B-Cell Non-Hodgkin Lymphoma. According to GlobalData,...